Disseminated mucormycosis and necrotizing fasciitis in immune-compromised patients: Two case reports by Mugambi, Machoki S. et al.
Disseminated mucormycosis and necrotizing fasciitis
in immune-compromised patients: two case reports
Machoki S. Mugambia, Andre Therona, Sharon Coxa, Komala Pillayb,
Alastair J.W. Millara and Alp Numanoglua
We present two case reports of disseminated
mucormycosis and necrotizing fasciitis in an immune-
compromised patient. First, a 3-month-old with untreated
HIV infection presented in septic shock with abdominal
wall-necrotizing fasciitis. Laparotomy revealed extensive
abdominal wall necrosis, bowel, liver, kidney and
subsequent retroperitoneal, posterior diaphragm and
inferior vena cava involvement. Second, a 3-year-old on
chemotherapy for Burkitt’s lymphoma presented with
pancytopenia, sepsis, abdominal wall-necrotizing fasciitis
and left lower limb ischaemia. At surgery, there was
necrosis of the abdominal wall, the large bowel and the
ureter and thrombosis of the iliac vessels. Histology in both
cases showed necrosis with fungal invasion consistent
with mucormycosis. Both patients suffered mortality. We
discuss mucormycosis and review the literature regarding
mucormycosis in immune-compromised paediatric
patients. Ann Pediatr Surg 11:35–39 c 2015 Annals of
Pediatric Surgery.
Annals of Pediatric Surgery 2015, 11:35–39
Keywords: child, immune-compromised, mucormycosis, necrotizing
fasciitis, paediatric
aDepartment of Paediatric Surgery and bNational Health Laboratory Service, Red
Cross War Memorial Children’s Hospital and University of Cape Town, Cape
Town, South Africa
Correspondence to Andre Theron, MBChB, Department of Paediatric Surgery,
6th Floor ICH Building, Red Cross War Memorial Children’s Hospital, Klipfontein
Road, Rondebosch, 7700 Western Cape, Cape Town, 7700 South Africa
Tel: + 27 21 658 5432; fax: + 27 21 685 6632;
e-mail: andre.theron@gmail.com
Received 25 August 2014 accepted 19 December 2014
Background
Mucormycosis is an infection caused by a fungus of the
order Mucorales. These fungi are found commonly in
organic matter and soil and have clinical relevance in
affecting mostly immune-compromised hosts. The infec-
tion can present in multiple ways, and if disseminated, is
fatal in most cases. Disseminated mucormycosis is also
rare in paediatric HIV/AIDS patients. Early recognition,
urgent histological confirmation and aggressive debride-
ment combined with amphotericin B therapy could
perhaps prevent the usual fatal outcome.
Case reports
Patient 1
A 3-month-old, 4 kg female patient was transferred from
an outside institution to our ICU, intubated and
ventilated for respiratory failure secondary to Pneumocystis
jiroveci pneumonia. She was being treated with sulfa-
methoxazole/trimethoprim. The patient had also been on
hydrocortisone for 5 days, which was later changed to oral
prednisolone. She was confirmed to have HIV/AIDS
infection on PCR assay with a CD4 count of 4 cells/mm3.
Cytomegalovirus was isolated on nasopharyngeal aspirate
and later in the blood with a viral load of 53 780 counts/
ml. While on treatment for P. jiroveci pneumonia,
ganciclovir for cytomegalovirus and abacavir, kaletra and
lamivudine for HIV, she developed thrombocytopenia. At
the referring institution, the abdominal wall had become
indurated, discolored and firm. Suspecting necrotizing
fasciitis, the indurated area was incised and a serous
effluent without features of necrosis was noted. Culture
of the fluid had no yield.
Increasing respiratory dysfunction required high flow
oscillatory ventilation. Empirical treatment with broad-
spectrum antibiotics and fluconazole was started. Sub-
sequent bronchoalveolar lavage and urine samples grew
candida on culture.
Abdominal distension, hepatomegaly associated with a
right-flank mass, persistence of the erythema and
induration and bloody stool developed over the following
72 h. A radiograph of the abdomen showed a paucity of
bowel gas and an ultrasound scan of the abdomen showed
significant ascites, a large hyperechoic liver and thickened
bowel loops (Fig. 1).
The patient was in septic shock with multiorgan
dysfunction, requiring inotropic support. On correction
of the coagulopathy and anaemia with blood product
administration, the patient underwent an exploratory
laparotomy while on high flow oscillatory ventilation in
the ICU. At surgery, the entire right abdominal wall was
found to have full-thickness dry necrosis, and there was
disintegration of the terminal ileum, the caecum and the
ascending colon, forming an inflammatory mass around a
central cavity filled with bowel effluent. The right kidney
and the ureter were necrotic, with a grey-black and
velvety appearance. The lateral duodenal wall serosa was
greyish, but not perforated. The inferior surface of the
right lobe of the liver was dusky, with a greyish
discoloration of the capsule. The abdominal wall was
excised to bleeding edges, the necrotic bowel was
resected and the ends tied off, a right nephrectomy was
performed and the undersurface of the liver was debrided
(Fig. 2). A modified Bogota bag was applied to the
abdominal wall fascia and low negative-pressure wound
closure was applied.
Subsequent to the aggressive damage control surgery,
the patient’s condition improved. Daily planned relook
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laparotomies revealed rapid progression of necrosis. At the
third operation, the destructive process had spread to the
psoas muscle, the iliac crest fascia and segments VI and
VIII of the liver. The sigmoid colon was also noted to have
an area of full-thickness necrosis. Histology of all the
resected specimens showed extensive necrosis, with
abundant fungal organisms consistent with mucormycosis
(Figs 3 and 4). The patient was commenced on liposomal
amphotericin B. At the fourth laparotomy, the necrosis had
progressed to involve the retroperitoneal paraspinal
muscles, the posterior right hemidiaphragm, the inferior
vena cava and the duodenum. The disease had advanced
further within the liver. At this stage, the patient was in
multiorgan failure and deemed unsalvageable. After
discussions with the parents, it was agreed to offer
palliative treatment only and the patient died within 24 h.
Patient 2
A 3-year-old male patient, who had completed the second
course of chemotherapy [COPDAM: C = cyclophospha-
mide, O = vincristine (oncovin), P = prednisolone, A =
doxorubicin (adriamycin), M = methotrexate] for Bur-
kitt’s lymphoma 2 weeks before, was admitted to ICU
with febrile neutropenia (white cells of 0.03 109/l),
severe mucositis, intestinal obstruction and a small
bullous lesion on the left lower abdomen. He also had a
swollen left leg with confirmed deep venous thrombosis
on Doppler ultrasonography.
The bullous lesion evolved rapidly within hours into a
necrotic patch signaling possible necrotizing fasciitis of
the abdominal wall (Fig. 5). The left lower limb became
ischaemic, swollen, cold and pulseless.
Fig. 1
An ultrasound image of patient 1 showing the thickened bowel loop
(asterix), hyperechoic liver and free fluid (arrow head and arrow
respectively).
Fig. 2
An intraoperative picture of patient 1. Note the empty renal bed
inferiorly, necrotic patch on the duodenum (arrow) and the necrotic liver.
The anterior abdominal wall has been excised.
Fig. 3
Patient 1: Right nephrectomy specimen showing extensive
haemorrhagic infarction.
Fig. 4
Patient 1: Haematoxylin and eosin stain showing broad nonseptate
fungal hyphae with 901 branching (arrow) consistent with that seen in
mucormycosis plugging vessels and infiltrating through the surrounding
necrotic tissue (high power).
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The patient was pancytopaenic, with a deranged liver and
normal renal function. Blood culture had previously grown
a vancomycin-resistant Enterococcus faecalum and a sensi-
tive Streptococcus oralis for which he was receiving linezolid
and meropenem. He was also managed on empirical
fluconazole and was receiving granulocyte colony-stimu-
lating factor and interferon.
At laparotomy, he was found to have extensive full-
thickness necrosis of the left lower abdominal wall and
necrotic segments of the small and the large bowel with
extensive greyish discoloration of the surrounding tissue
including the left ureter (Fig. 6). The left iliac vein and
artery were thrombosed with extension into the femoral
vessels. Extensive necrosectomy of the anterior abdom-
inal wall, necrotic bowel resection and arterial and venous
thrombectomy were performed with a negative-pressure
dressing for the abdominal wall closure, and planned
relook in 24–48 h after further resuscitation. On clinical
suspicion of mucormycosis, the patient was commenced
on liposomal amphotericin B pending tissue cultures and
histology.
Postoperatively, the patient remained ventilated, suffered
rapid progressive multiorgan failure and died within 48 h.
Histology sections of both cases showed extensive
infarction as a result of mycotic thrombosis with a
variable inflammatory response. Broad nonseptate fungal
hyphae with 901 branching consistent with that seen in
mucormycosis were observed plugging vessels and
infiltrating through to the surrounding necrotic tissue
(Fig. 4). The fungal organisms were eventually confirmed
as Rhizopus spp. on one of the culture specimens from
patient 1, but no fungal organisms were cultured from any
of the tissue specimens submitted to microbiology for
patient 2.
Discussion
Mucormycosis is a fungal infection caused by moulds of
the class Zygomycetes, order Mucorales, with Rhizopus being
the most common pathogenic species. The other species
known to cause infections include Rhizomucor spp., Absidia
corymbifera, Apophysomyces elegans, Cunninghamella bertholle-
tiae, Mucor spp. and Saksenaea vasiformis [1,2]. Zygomycetes
are found commonly in organic matter and soil [3,4].
The fungus may gain entry through the nasopharynx by
inhalation of spores, can be swallowed in contaminated
food, fruits or vegetables, or invade through broken skin
or mucosa [1,3]. Host susceptibility is dependent on the
status of the immune defense. The exact mechanisms at
play in the process of host colonization, fungal growth,
virulence, invasion and dissemination are unclear. How-
ever, it is evident from histopathological assessment of
affected tissues that the mucor invades vessels leading to
thrombosis and tissue necrosis. Both of the reported cases
had small-vessel and large-vessel involvement. The
resulting anaerobic, high-CO2 environment seems to
stimulate further fungal growth, virulence and spread,
while impairing phagocytic function [1,4]. The infarcted,
necrotic tissue in patient 1 had a greyish hue with a dry
velvety texture (Fig. 3).
Cases of mucor on wounds as well as other hospital-
acquired sources of infection have been reported [5,6].
The infection can present as rhinocerebral, central
nervous system, pulmonary, cutaneous and gastrointest-
inal, or can be disseminated. Cases of mucormycosis
infection in healthy, immune-competent individuals are
rare and tend to be focal [7]. The disease affects mostly
immune-compromised hosts, and in this situation, is
invasive in most cases [8–11].
Diagnosis is often difficult and delayed. Tissue and blood
cultures take time and can be unrevealing, whereas
results from swabs of the nasopharynx and tracheal
Fig. 5
Patient 2: Anterior abdominal wall lesion.
Fig. 6
Patient 2: Clinical appearance of the bowel and the abdominal wall at
laparotomy.
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aspirates are difficult to interpret due to the ubiquitous
nature of this fungus. In both cases, tissue fungal cultures
at 45 days had no yield. The diagnosis was made on
histology of the resected necrotic tissue. Urgent proces-
sing of histological specimens is therefore critical in
suspected cases.
Disseminated mucormycosis is fatal in most cases [12].
Although it tends to occur in immune-compromised
patients on chemotherapy or steroids, patients with
diabetic ketoacidosis, transplant patients and patients in
renal failure, only a few cases have been reported in
paediatric and in paediatric HIV/AIDS patients. The
underlying predisposition seems to be the loss of
phagocytic function as demonstrated in neutropaenic
patients after chemotherapy or immunosuppressive
treatment after transplantation. It is relatively rare in
HIV/AIDS patients, in whom the primary disorder is the
loss of T-cell function [1]. In neonates, intestinal
mucormycosis can mimic necrotizing enterocolitis [13].
Cases of paediatric patients with disseminated mucormy-
cosis presenting with necrotizing fasciitis are uncom-
mon [14,15]. This is possibly due to the failure to
recognize it in a patient with a comorbidity, multiorgan
dysfunction and what seems to be unabated necrotizing
fasciitis.
Chen et al. [16] reported a case of fatal disseminated
mucor coinfection with bacteria causing necrotizing
fasciitis in a 71-year-old patient. A case of limb salvage
in the setting of regional mucormycosis with necrotizing
fasciitis has been reported in an adult patient after renal
transplant with underlying diabetes [17]. Our second
patient had associated limb ischaemia and subsequent
infarction of the left lower limb secondary to thrombosis
of the involved iliac vessels.
The key to treatment is early recognition, urgent
histological confirmation and aggressive debridement
combined with effective antifungal therapy and reversal
of the underlying immunosuppression [12]. Radiological
imaging as an adjunct to diagnosis is important in
assessing regions that are not readily available to surgical
exploration or clinical assessment [18,19].
These fungi are resistant to the azole group of
antifungals, but sensitive to amphotericin B. However,
empirical or prophylactic use of amphotericin B is
precluded by its toxicity and, in some situations, cost.
Liposomal amphotericin B is potentially less toxic and has
better tissue penetration. There are reports of mucormy-
cosis treatment with posaconazole and other newer
agents [20,21]. Some recommend the use of posaconazole
in empirical therapy or prophylaxis in select patients [22].
Experience with such cases raises a pertinent question:
When does the hope for benefit from empiric but
potentially toxic antifungal therapy and/or explorative
surgery outweigh the potential risks? Particularly in a
patient who is already in multiorgan dysfunction with
high perioperative risk of morbidity and further deteriora-
tion of renal function from amphotericin B.
Empirical therapy in cases with a high clinical suggestion
of mucormycosis is as valid as that for early biopsy of
affected tissues and aggressive debridement. The
patients presented here had rapid progression of disease
and early mortality. Immunoglobulins and granulocyte
colony-stimulating factor have also been used [23].
Mortality is high in noncontiguous organ/systemic in-
volvement, particularly in the setting of extreme
immunological failure. There are case reports of success-
ful treatment of regional mucormycosis with a combina-
tion of posaconazole, antifungal wound packs and
hyperbaric oxygen [24,25].
Conclusion
The two cases reported illustrate the challenges in the
early diagnosis and the poor outcome in paediatric
patients with profound immunological failure and multi-
organ mucormycosis.
Empiric therapy in suspected mucormycosis must be
guided by clinical suspicion. Unfortunately, identifying
early mucormycosis in a patient with multiple other
problems that can explain the presentation is a clinical
challenge. Cultures will take time and may not be
reliable. Frozen section for histological confirmation is
possible. Further studies on new, less toxic antifungal
agents is essential.
The utility of a disease-reporting system including new
modes of presentation in specific populations is essential
in raising awareness among clinicians and researchers.
Consent for inclusion of clinical and photographic
material in this manuscript was obtained from the legal
guardians of both patients.
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